Table 1.
Indicator | Issues identified | ||
Conceptualisation | Measurement | Aggregation | |
Publications | It is unclear how or when publications capture meaningful collaborations versus tokenistic ones. | It is also unclear how to combine article with differing contributions (first, last or any author) to reflects goals of HR development. | |
Clinical trials | This biases attention to some forms of research (eg, clinical/epidemiological). | The metric cannot easily measure relevance to local needs. | |
Patents filed | Counts do not distinguish usefulness or quality. | ||
Research institutions | Unclear what constitutes a relevant institution. | Quality hard to assess (in context). | Unclear how to weigh the value of large centres of excellence versus smaller institutions. |
Research personnel | Lack of clarity on what constitutes research staff or how to include support elements. | Quality hard to assess. | Unclear how to combine different types of researchers into a single indicator. |
Resources for HR | Unclear when or how domestic versus international funding matters to HR performance. | Lack of standard national budget lines to identify comparable spending. | |
Policies and regulations | Not clear what constitutes relevant policies, and these may be context-sensitive. | Actual impact or influence of policies and regulations hard to evaluate. | Unclear how to combine elements such as policies, supportive regulations and agencies into a single indicator. |
HR, health research.